covid-19
Conditions
Interventions
control group:Jingyin Gubiao granule very low dose (1 / 10 dose)
Test group:Jingyin Gubiao granule
Sponsors
Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: (1) Age 18-60 years old (including 18 and 60 years old), regardless of gender; (2) covid-19 showed positive results, but no new Coronet pneumonia related clinical symptoms. (3) Voluntarily participate in the experiment and sign the written informed consent.
Exclusion criteria
Exclusion criteria: (1) Complicated with influenza, other pneumonia, suppurative tonsillitis, acute tracheobronchial inflammation, pulmonary tuberculosis, primary ciliary dyskinesia syndrome, and other acute nasal diseases (such as allergic rhinitis, acute and chronic rhinitis, acute and chronic sinusitis, etc.); (2) During the course of the disease, he has received other oral drugs for the disease before treatment, such as cold drugs, antiviral drugs, antibiotics, traditional Chinese medicine and other drugs; (3) Accompanied by gastrointestinal discomfort symptoms such as acute and chronic diarrhea; (4) merge serious serious diseases such as heart, brain, lung, liver, kidney and blood system, such as viral hepatitis, hemophilia, diabetes mellitus, mental illness, etc. (5) Pregnant or planned pregnant women, lactating women, patients of childbearing age who are unable or unwilling to take adequate contraception during the trial, or their spouses are unwilling to take contraception; (6) Allergic constitution, such as a history of allergy to more than two drugs or foods, or known allergy to various components of the drug in this study; (7) Participate in or are participating in other drug clinical trials within 3 months; (8) According to the judgment of the researcher, there are other diseases or conditions that reduce the possibility of enrollment or complicate enrollment, such as pregnancy, frequent changes in working environment, unstable living environment and other conditions that are easy to cause loss of follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Average nucleic acid negative time;Detection of N gene and ORF gene Ct value by New Coronavirus nucleic acid; | — |
Secondary
| Measure | Time frame |
|---|---|
| Conversion rate; | — |
Countries
CHINA
Contacts
Public Contactzhangwei
Outcome results
None listed